Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Schein

Showing results (141-150 of 218) with videos related to

Pageof 22
Sort By:
Cancer|February 11, 1975
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapyP S Schein, B A Chabner, G P Canellos, et al.
Lancet (London, England)|June 16, 1973
Maintenance chemotherapy for advanced Hodgkin's disease in remissionR C Young, G P Canellos, B A Chabner, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cellsK B Tan, M R Mattern, R A Boyce, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasmJ S Macdonald, M E Lippman, P V Woolley, et al.
Radiology|January 1, 1976
Osteoblastic bone metastasis in Zollinger-Ellison syndromeR T Pederson, D J Haidak, R A Ferris, et al.
Journal of Immunogenetics|June 1, 1989
Lack of common haplotype among four family members with late-onset Kaposi's sarcomaJ R Neefe, J A Treat, B K Chun, et al.
Investigational New Drugs|January 1, 1984
A Phase I trial of spirogermanium administered on a continuous infusion scheduleP V Woolley, J D Ahlgren, P J Byrne, et al.
Cancer|July 1, 1979
5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancerJ S MacDonald, P V Woolley, T Smythe, et al.
Cancer Treatment Reports|April 1, 1978
Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancerD G Haller, P V Woolley, J S Macdonald, et al.
Clinical Pharmacology and Therapeutics|January 1, 1970
The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in manP S Schein, R D Davis, S Carter, et al.
Pageof 22

Showing results (141-150 of 218) with videos related to

Sort By:
Pageof 22
Cancer|February 11, 1975
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapyP S Schein, B A Chabner, G P Canellos, et al.
Lancet (London, England)|June 16, 1973
Maintenance chemotherapy for advanced Hodgkin's disease in remissionR C Young, G P Canellos, B A Chabner, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cellsK B Tan, M R Mattern, R A Boyce, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasmJ S Macdonald, M E Lippman, P V Woolley, et al.
Radiology|January 1, 1976
Osteoblastic bone metastasis in Zollinger-Ellison syndromeR T Pederson, D J Haidak, R A Ferris, et al.
Journal of Immunogenetics|June 1, 1989
Lack of common haplotype among four family members with late-onset Kaposi's sarcomaJ R Neefe, J A Treat, B K Chun, et al.
Investigational New Drugs|January 1, 1984
A Phase I trial of spirogermanium administered on a continuous infusion scheduleP V Woolley, J D Ahlgren, P J Byrne, et al.
Cancer|July 1, 1979
5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancerJ S MacDonald, P V Woolley, T Smythe, et al.
Cancer Treatment Reports|April 1, 1978
Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancerD G Haller, P V Woolley, J S Macdonald, et al.
Clinical Pharmacology and Therapeutics|January 1, 1970
The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in manP S Schein, R D Davis, S Carter, et al.
Pageof 22